Renal dosimetry

Cancer Biotherapy and Radiopharmaceuticals

Volumn 25, Issue 5, 2010, Pages 597-599

  Wessels, Barry W ^a   Dale, Roger G ^b   Cremonesi, Marta ^c   Meredith, Ruby F ^d   Green, Alan J ^e   Brill, Bertrand ^f   Bolch, Wesley E ^g   Sgouros, George ^h   Thomas, Stephen R ⁱ  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f VANDERBILT UNIVERSITY   (United States)

^g UNIVERSITY OF FLORIDA   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RADIOPHARMACEUTICAL AGENT;

DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; KIDNEY FAILURE; LETTER; MEDICAL LITERATURE; PEPTIDE RADIONUCLIDE RECEPTOR THERAPY; PRIORITY JOURNAL; PUBLICATION; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; RADIOTHERAPY;

HUMANS; KIDNEY; MODELS, THEORETICAL; PAMPHLETS; PREDICTIVE VALUE OF TESTS; RADIATION DOSAGE; RADIOMETRY;

EID: 77958186202     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2010.0867     Document Type: Letter

References (10)

1. Wessels BW, Konijnenberg MW, Dale RG, et al. MIRD Pamphlet No. 20: The effect of model assumptions on kidney dosimetry and response-implications for radionuclide therapy. J Nucl Med 2008;49:1884.
2. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109.
3. Dawson LA, Kavanagh BD, Paulino AC, et al. Radiationassociated kidney injury. Int J Radiat Oncol Biol Phys 2010;76: S108.
4. Cremonesi M, Ferrari M, Bodei L, et al. Dosimetry in peptide radionuclide receptor therapy: A review. J Nucl Med 2006;47:1467.
5. Bouchet LG, Bolch WE, Blanco HP, et al. MIRD Pamphlet No 19: Absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney. J Nucl Med 2003;44:1113.
6. Geara FB, Peters LJ, Ang KK, et al. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 1993;27:1173.
7. Hall EJ. Radiobiology for the Radiologist, 2nd ed. Philadelphia: Harper & Row, 1978.
8. Fowler JF. 21 years of biologically effective dose. Br J Radiol 2010;83:554.
9. Brenner DJ, Hlatky LR, Hahnfeldt PJ, et al. The linearquadratic model and most other common radiobiological models result in similar predictions of time-dose relationships. Radiat Res 1998;150:83.
10. Thames HD and Hendry JH. Fractionation in Radiotherapy. London: Taylor & Francis, 1987.